, /PRNewswire/ -- Today, the U.S. Food and Drug Administration is advancing its mission of ensuring the public has access to accurate, up-to-date science-based information to inform decisions about FDA-regulated medical products to maintain and improve their health.
The agency is providing updated recommendations to empower industry seeking to voluntarily address misinformation about or related to their approved/cleared medical products. In today's health care system, health care providers and consumers often turn to the internet to obtain health and medical-related information. However, not all information found online about medical products is reliable.
There are many false statements and conclusions shared online and the structure and popularity of social media platforms have meant that false, inaccurate and/or misleading information about medical products can spread rapidly to a broad audience. Basing medical decisions on inaccurate information can have adverse consequences as it can lead patients and health care providers to choose treatments that are not safe and effective, or to forgo treatments that are. The FDA believes it is critically important to promptly address misinformation about medical products.
The revised draft guidance issued today supports the efforts of medical product companies that share this interest in helping the public get factual, accurate and scientifically sound information about medical products. Specifically, the revised draft guidance, sets .